Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
PubMed
28556820
PubMed Central
PMC5483618
DOI
10.3390/children4060043
PII: children4060043
Knihovny.cz E-zdroje
- Klíčová slova
- long-term outcome, placebo by proxy, preterm infants, randomized controlled trial,
- Publikační typ
- časopisecké články MeSH
Placebo effects emerging from the expectations of relatives, also known as placebo by proxy, have seldom been explored. The aim of this study was to investigate whether in a randomized controlled trial (RCT) there is a clinically relevant difference in long-term outcome between very preterm infants whose parents assume that verum (PAV) had been administered and very preterm infants whose parents assume that placebo (PAP) had been administered. The difference between the PAV and PAP infants with respect to the primary outcome-IQ at 5 years of age-was considered clinically irrelevant if the confidence interval (CI) for the mean difference resided within our pre-specified ±5-point equivalence margins. When adjusted for the effects of verum/placebo, socioeconomic status (SES), head circumference and sepsis, the CI was [-3.04, 5.67] points in favor of the PAV group. Consequently, our study did not show equivalence between the PAV and PAP groups, with respect to the pre-specified margins of equivalence. Therefore, our findings suggest that there is a small, but clinically irrelevant degree to which a preterm infant's response to therapy is affected by its parents' expectations, however, additional large-scale studies are needed to confirm this conjecture.
Child Development Centre University Children's Hospital 8032 Zürich Switzerland
Department of Mathematics and Statistics Masaryk University 611 37 Brno Czech Republic
Department of Neonatology University Hospital Zürich 8091 Zürich Switzerland
Zobrazit více v PubMed
Finniss D.G., Kaptchuk T.J., Miller F., Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375:686–695. doi: 10.1016/S0140-6736(09)61706-2. PubMed DOI PMC
Kaptchuk T.J., Miller F.G. Placebo effects in medicine. N. Engl. J. Med. 2015;373:8–9. doi: 10.1056/NEJMp1504023. PubMed DOI
LeWitt P.A., Kim S. The pharmacodynamics of placebo: Expectation effects of price as a proxy for efficacy. Neurology. 2015;84:766–767. doi: 10.1212/WNL.0000000000001294. PubMed DOI
Grelotti D.J., Kaptchuk T.J. Placebo by proxy. BMJ. 2011;343:d4345. doi: 10.1136/bmj.d4345. PubMed DOI PMC
Conzemius M.G., Evans R.B. Caregiver placebo effect for dogs with lameness from osteoarthritis. J. Am. Vet. Med. Assoc. 2012;241:1314–1319. doi: 10.2460/javma.241.10.1314. PubMed DOI
Whalley B., Hyland M.E. Placebo by proxy: The effect of parents’ beliefs on therapy for children’s temper tantrums. J. Behav. Med. 2013;36:341–346. doi: 10.1007/s10865-012-9429-x. PubMed DOI
Fauchere J.C., Dame C., Vonthein R., Koller B., Arri S., Wolf M., Bucher H.U. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics. 2008;122:375–382. doi: 10.1542/peds.2007-2591. PubMed DOI
Melchers P., Preuss U. Kaufman assessment battery for children (german version) Frankf. Am. Main Pearson Assess. 2009
Largo R.H., Graf S., Kundu S., Hunziker U., Molinari L. Predicting developmental outcome at school age from infant tests of normal, at-risk and retarded infants. Dev. Med. Child Neurol. 1990;32:30–45. doi: 10.1111/j.1469-8749.1990.tb08464.x. PubMed DOI
Jones B., Jarvis P., Lewis J.A., Ebbutt A.F. Trials to assess equivalence: The importance of rigorous methods. BMJ. 1996;313:36–39. doi: 10.1136/bmj.313.7048.36. PubMed DOI PMC
Piaggio G., Elbourne D.R., Pocock S.J., Evans S.J., Altman D.G., Group C. Reporting of noninferiority and equivalence randomized trials: Extension of the consort 2010 statement. JAMA. 2012;308:2594–2604. doi: 10.1001/jama.2012.87802. PubMed DOI
Mangione-Smith R., McGlynn E.A., Elliott M.N., Krogstad P., Brook R.H. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics. 1999;103:711–718. doi: 10.1542/peds.103.4.711. PubMed DOI
Bauchner H., Pelton S.I., Klein J.O. Parents, physicians, and antibiotic use. Pediatrics. 1999;103:395–401. doi: 10.1542/peds.103.2.395. PubMed DOI
Jiang S.Y., Warre R., Qiu X.M., O’Brien K., Lee S.K. Parents as practitioners in preterm care. Early Hum. Dev. 2014;90:781–785. doi: 10.1016/j.earlhumdev.2014.08.019. PubMed DOI
Ruegger C.M., Kraus A., Koller B., Natalucci G., Latal B., Waldesbuhl E., Fauchere J.C., Held L., Bucher H.U. Randomized controlled trials in very preterm infants: Does inclusion in the study result in any long-term benefit? Neonatology. 2014;106:114–119. doi: 10.1159/000362784. PubMed DOI
Rheims S., Cucherat M., Arzimanoglou A., Ryvlin P. Greater response to placebo in children than in adults: A systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008;5:e166. doi: 10.1371/journal.pmed.0050166. PubMed DOI PMC
Janiaud P., Cornu C., Lajoinie A., Djemli A., Cucherat M., Kassai B. Is the perceived placebo effect comparable between adults and children? A meta-regression analysis. Pediatr. Res. 2017;81:11–17. doi: 10.1038/pr.2016.181. PubMed DOI
Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol. Rev. 2013;93:1207–1246. doi: 10.1152/physrev.00043.2012. PubMed DOI PMC
Hall K.T., Loscalzo J., Kaptchuk T.J. Genetics and the placebo effect: The placebome. Trends Mol. Med. 2015;21:285–294. doi: 10.1016/j.molmed.2015.02.009. PubMed DOI PMC
Price D.D., Finniss D.G., Benedetti F. A comprehensive review of the placebo effect: Recent advances and current thought. Annu. Rev. Psychol. 2008;59:565–590. doi: 10.1146/annurev.psych.59.113006.095941. PubMed DOI
Colloca L., Benedetti F. Placebo analgesia induced by social observational learning. Pain. 2009;144:28–34. doi: 10.1016/j.pain.2009.01.033. PubMed DOI
Singer L.T., Fulton S., Kirchner H.L., Eisengart S., Lewis B., Short E., Min M.O., Kercsmar C., Baley J.E. Parenting very low birth weight children at school age: Maternal stress and coping. J. Pediatrics. 2007;151:463–469. doi: 10.1016/j.jpeds.2007.04.012. PubMed DOI PMC
Muller-Nix C., Forcada-Guex M., Pierrehumbert B., Jaunin L., Borghini A., Ansermet F. Prematurity, maternal stress and mother-child interactions. Early Hum. Dev. 2004;79:145–158. doi: 10.1016/j.earlhumdev.2004.05.002. PubMed DOI
Forcada-Guex M., Borghini A., Pierrehumbert B., Ansermet F., Muller-Nix C. Prematurity, maternal posttraumatic stress and consequences on the mother-infant relationship. Early Hum. Dev. 2011;87:21–26. doi: 10.1016/j.earlhumdev.2010.09.006. PubMed DOI
Shah E., Pimentel M. Placebo effect in clinical trial design for irritable bowel syndrome. J. Neurogastroenterol. Motil. 2014;20:163–170. doi: 10.5056/jnm.2014.20.2.163. PubMed DOI PMC
Curie A., Yang K., Kirsch I., Gollub R.L., des Portes V., Kaptchuk T.J., Jensen K.B. Placebo responses in genetically determined intellectual disability: A meta-analysis. PLoS ONE. 2015;10:e0133316. doi: 10.1371/journal.pone.0133316. PubMed DOI PMC
Johnson T.P., Wislar J.S. Response rates and nonresponse errors in surveys. JAMA. 2012;307:1805–1806. doi: 10.1001/jama.2012.3532. PubMed DOI
Jones M.P. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J. Am. Stat. Assoc. 1996;91:222–230. doi: 10.1080/01621459.1996.10476680. DOI